Skip to main content
Top
Published in:

13-08-2024 | Computed Tomography

A machine learning-based pipeline for multi-organ/tissue patient-specific radiation dosimetry in CT

Authors: Eleftherios Tzanis, John Damilakis

Published in: European Radiology | Issue 2/2025

Login to get access

Abstract

Objectives

To develop a machine learning-based pipeline for multi-organ/tissue personalized radiation dosimetry in CT.

Materials and methods

For the study, 95 chest CT scans and 85 abdominal CT scans were collected retrospectively. For each CT scan, a personalized Monte Carlo (MC) simulation was carried out. The produced 3D dose distributions and the respective CT examinations were utilized for the development of organ/tissue-specific dose prediction deep neural networks (DNNs). A pipeline that integrates a robust open-source organ segmentation tool with the dose prediction DNNs was developed for the automatic estimation of radiation doses for 30 organs/tissues including sub-volumes of the heart and lungs. The accuracy and time efficiency of the presented methodology was assessed. Statistical analysis (t-tests) was conducted to determine if the differences between the ground truth organ/tissue radiation dose estimates and the respective dose predictions were significant.

Results

The lowest median percentage differences between MC-derived organ/tissue doses and DNN dose predictions were observed for the lung vessels (4.3%), small bowel (4.7%), pulmonary artery (4.7%), and colon (5.2%), while the highest differences were observed for the right lung’s upper lobe (13.3%), spleen (13.1%), pancreas (12.1%), and stomach (11.6%). Statistical analysis showed that the differences were not significant (p-value > 0.18). Furthermore, the mean inference time, regarding the validation cohort, of the developed methodology was 77.0 ± 11.0 s.

Conclusion

The proposed workflow enables fast and accurate organ/tissue radiation dose estimations. The developed algorithms and dose prediction DNNs are publicly available (https://​github.​com/​eltzanis/​multi-structure-CT-dosimetry).

Clinical relevance statement

The accuracy and time efficiency of the developed pipeline compose a useful tool for personalized dosimetry in CT. By adopting the proposed workflow, institutions can utilize an automated pipeline for patient-specific dosimetry in CT.

Key Points

  • Personalized dosimetry is ideal, but is time-consuming.
  • The proposed pipeline composes a tool for facilitating patient-specific CT dosimetry in routine clinical practice.
  • The developed workflow integrates a robust open-source segmentation tool with organ/tissue-specific dose prediction neural networks.

Graphical Abstract

Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
A machine learning-based pipeline for multi-organ/tissue patient-specific radiation dosimetry in CT
Authors
Eleftherios Tzanis
John Damilakis
Publication date
13-08-2024
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2025
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-024-11002-0

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest